| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/25/2009 | CN100463675C Soluble slow release external applied contraceptive |
| 02/25/2009 | CN100463674C Oral cavity quick dissolved film containing civeran and method for preparing the same |
| 02/25/2009 | CN100463673C Compound medicine release controlling film of chitosan, sodium alginate and gelatin and its preparing process |
| 02/25/2009 | CN100463672C Method for preparing large quantity of micro-capsule |
| 02/25/2009 | CN100463670C Microemulsion concentrate for oral administration of water-insoluble anti-cold drug and method for preparing same |
| 02/25/2009 | CN100463669C Self-emulsifying agent of compound artemether |
| 02/25/2009 | CN100463668C Reversibly hot gelified water soluble medicine composition |
| 02/24/2009 | US7495115 Androgens conjugated with mammalian proteins; diagnosis or treatment of solid cancer and hematological malignancies; exhibit synergistic action together with a cytoskeleton-acting drug; prostate cancer |
| 02/24/2009 | US7495099 Polyethylene glycol-polyglutamic acid block copolymer conjugates with e.g. 7-ethyl-10-hydroxycamptothecin or topotecan for sustained release; water solubility, anticancer agents |
| 02/24/2009 | US7495030 (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents |
| 02/24/2009 | US7494975 A polyanion selected from a heparin, a dextran, a pentosan, resobene, curdian sulfate, or 2-naphthalene sulfonate polymer and a CD4 polypeptide with a beta-hairpin confirmation; blocking HIV interaction with coreceptors |
| 02/24/2009 | US7494824 Interactive system for presenting and eliminating substances |
| 02/24/2009 | US7494785 Recombinant subunit vaccine |
| 02/24/2009 | US7494680 Fat or oil composition |
| 02/24/2009 | US7494669 Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
| 02/24/2009 | US7494666 Administering to a mammal a formualtion comprising cationic lipids/DNA complex, allowing the complex to associate with angiogenic endothelial cells of an angiogenic blood vessel for a time such that the complex enters the target cells |
| 02/24/2009 | US7494649 Drug conjugate composition |
| 02/24/2009 | US7494503 Method and apparatus for acne prevention |
| 02/24/2009 | CA2462741C Dry liposomal pvp-iodine compositions |
| 02/24/2009 | CA2443543C Supplementation of equine feedstuffs |
| 02/24/2009 | CA2440333C Process for obtention of decoctions of vitis labrusca and vitis vinifera skins |
| 02/24/2009 | CA2416109C Solid dose nanoparticulate compositions |
| 02/24/2009 | CA2362601C Deep penetrating antimicrobial compositions |
| 02/24/2009 | CA2354472C Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings |
| 02/24/2009 | CA2341297C Dosage form comprising liquid formulation |
| 02/24/2009 | CA2339913C Pharmaceutical formulations and method for making |
| 02/24/2009 | CA2338605C Pliable and moldable polymeric delivery system for bioactive agents |
| 02/24/2009 | CA2329129C Stable gene formulations comprising saccharides |
| 02/24/2009 | CA2188043C 7,11 disubstituted camptothecin derivatives, formulations containing such derivatives and their use |
| 02/24/2009 | CA2177668C Mammalian vaccine compositions comprising squalene or squalane, glycerol and a surfactant as an adjuvant |
| 02/24/2009 | CA2152949C Vaccine preparations |
| 02/21/2009 | CA2638952A1 Anhydrous compositions useful for attaining enhanced sexual wellness |
| 02/19/2009 | WO2009023826A1 Protein-polymer conjugates |
| 02/19/2009 | WO2009023742A2 Spore displaying antigens |
| 02/19/2009 | WO2009023473A2 Antimicrobial parenteral formulation |
| 02/19/2009 | WO2009023177A1 Polymer therapy for the treatment of chronic microvascular diseases |
| 02/19/2009 | WO2009023014A1 Emamectin compositions and methods |
| 02/19/2009 | WO2009022761A1 Dissolvable nano web porous film and method of preparing the same |
| 02/19/2009 | WO2009022756A1 Diagnosis and treatment of ischemic disease |
| 02/19/2009 | WO2009022674A1 Medical composition containing rebamipide |
| 02/19/2009 | WO2009022670A1 Quickly disintegrating tablet |
| 02/19/2009 | WO2009022340A1 Peptides and pharmaceutical compositions for treating connective tissue |
| 02/19/2009 | WO2009021840A1 Injectable pharmaceutical formulation of taxoids |
| 02/19/2009 | WO2009021808A1 Increasing the efficiency of utilization of ingested creatine |
| 02/19/2009 | WO2009021735A1 Increased creatine retention with soluble fibres |
| 02/19/2009 | WO2009021728A2 Targeted block copolymer micelles |
| 02/19/2009 | WO2009021377A1 Non-gelatin shell material of hard capsule and process for preparing thereof |
| 02/19/2009 | WO2009004440A3 Quick dissolve compositions of memantine hydrochloride |
| 02/19/2009 | WO2008157288A3 A baclofen solution for low-volume therapeutic delivery |
| 02/19/2009 | WO2008148057A3 Cationic lipids compositions and methods for enhancing immune responses to vaccines |
| 02/19/2009 | WO2008140507A9 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof |
| 02/19/2009 | WO2008133789A4 Methods and compositions for targeting afap |
| 02/19/2009 | WO2008120181A4 A method of producing fast dissolving tablets |
| 02/19/2009 | WO2008118013A3 Targeted intracellular delivery of antiviral agents |
| 02/19/2009 | WO2008088422A3 Toxin peptide therapeutic agents |
| 02/19/2009 | WO2007039858A3 Targeted imaging and/or therapy using the [3+2] azide-alkyne cycloaddition |
| 02/19/2009 | US20090048667 Controlled Drug-Release Composition and Drug-Releasable Medical Device |
| 02/19/2009 | US20090048350 Gastrointestinal absorption enhancer mediated by proton-coupled transporter and its preparing method |
| 02/19/2009 | US20090048349 Compositions and kits for compounding pharmaceuticals |
| 02/19/2009 | US20090048331 Methods and formulations for the delivery of pharmacologically active agents |
| 02/19/2009 | US20090048284 Therapeutic compounds |
| 02/19/2009 | US20090048206 Edible powder meterial having excellent shelf stability |
| 02/19/2009 | US20090048201 Use of targeted cross-linked nanoparticles for in vivo gene delivery |
| 02/19/2009 | US20090048198 Compositions and methods for nucleic acid delivery systems |
| 02/19/2009 | US20090048180 Sustained-release preparation |
| 02/19/2009 | US20090048151 PEG-Poly(Ortho Ester) Graft Copolymers and Pharmaceutical Compositions |
| 02/19/2009 | US20090048149 Antagonists of the bradykinin B1 receptor |
| 02/19/2009 | US20090048148 Compositions and methods for therapeutic use |
| 02/19/2009 | US20090048145 In situ hardening paste, its manufacturing and use |
| 02/19/2009 | US20090047366 Inorganic Coagulation Accelerators for Individuals taking Platelet Blockers or Anticoagulants |
| 02/19/2009 | US20090047358 Phospholipid-based powders for drug delivery |
| 02/19/2009 | US20090047347 Compositions for Drug Administration |
| 02/19/2009 | US20090047344 Formulations |
| 02/19/2009 | US20090047336 novel formulation of dehydrated lipid vesicles for controlled release of active pharmaceutical ingredient via inhalation |
| 02/19/2009 | US20090047312 Microgel and external compositions containing the same |
| 02/19/2009 | US20090047306 Adjuvant compositions |
| 02/19/2009 | US20090047296 Antibodies conjugated to Auristatin analogs via a maleimidocaproyl lingages; for treating cancer, autoimmune diseases and infectious diseases |
| 02/19/2009 | US20090047261 Composition For Treatment Of Articular Cartilage Damage |
| 02/19/2009 | US20090047256 Biodegradable Elastomers |
| 02/19/2009 | US20090047251 Conjugates of hydroxyalkyl starch and a protein |
| 02/19/2009 | US20090047234 Compositions for nasal delivery |
| 02/19/2009 | US20090047227 Cationic Cassia Derivatives and Applications Therefor |
| 02/19/2009 | CA2697265A1 Method of treating autoimmune disease with mesenchymal stem cells |
| 02/19/2009 | CA2696478A1 Protein-polymer conjugates |
| 02/19/2009 | CA2696330A1 Novel forms of cddo methyl ester |
| 02/19/2009 | CA2695892A1 Non-aggregating virus formulation |
| 02/19/2009 | CA2695374A1 Compositions and methods for modifying properties of biologically active polypeptides |
| 02/19/2009 | CA2695151A1 Polymer therapy for the treatment of chronic microvascular diseases |
| 02/19/2009 | CA2693041A1 Antimicrobial parenteral formulation |
| 02/18/2009 | EP2025757A2 Polymeric immunoglobulin receptor-mediated gene transfer |
| 02/18/2009 | EP2025353A2 Injectable polysaccharide-cell compositions |
| 02/18/2009 | EP2025348A1 Targeted block copolymer micelles |
| 02/18/2009 | EP2025345A1 KIM-1 antagonists and use to modulate immune system |
| 02/18/2009 | EP2025344A1 Melanoma Therapy |
| 02/18/2009 | EP2025339A1 WATER SOLUTION OF 20(R)-GINSENOSIDE Rg3 PHARMACEUTICAL COMPOSITION AND PROCESS THEREOF |
| 02/18/2009 | EP2025337A1 External pharmaceutical composition |
| 02/18/2009 | EP2025333A1 Injectable pharmaceutical formulation of taxoids |
| 02/18/2009 | EP2024398A1 Method of producing polysaccharide derivatives |
| 02/18/2009 | EP2024396A2 Plad domain peptides with increased serum half life due to conjugation to domain antibodies |
| 02/18/2009 | EP2024390A1 Insulin derivative |